CTRI/2019/03/018135
Recruiting
Phase 3
Evaluation of outer retinal layers after Intravitreal AntiVEGF Therapy in Diabetic Macular Edema - ORLBT
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: H350- Background retinopathy and retinalvascular changes
- Sponsor
- Department of Ophthalmology
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. All consecutive cases of Type 2 DM, between age group 40\-65 years, attending Retina Clinic of Department of Ophthalmology, K.G.M.U., Lucknow
- •2\. In asymmetrical involvement, the eye with more severe form of the disease will be included
Exclusion Criteria
- •1\.Patients with any other ocular or systemic disease which can affect the retinal vasculature( Ischemic heart disease)
- •2\. Previous intravitreal injection(s), ophthalmic surgical or laser interventions
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Patient with diabetic retinopathy undergoing intravitreal Avastin injection.CTRI/2018/04/012956Giridhar Eye Institute20
Active, not recruiting
Not Applicable
Macular structure and function after intravitreal injection of bevacizumab for wet macular degeneration a interventional study. - NDEUCTR2005-006014-18-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI20
Active, not recruiting
Not Applicable
Macular structure and function after intravitreal injection of bevacizumab for vascular retinopathy a interventional study. - NDvascular retinopathyMedDRA version: 6.1Level: PTClassification code 10038923EUCTR2006-001678-25-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI20
Recruiting
Phase 2
Comparative study of the effect of intravitreal injection of bevacizumab versus simultaneous intravitreal injection of bevacizumab and triamcinolone acetonideRetinal vascular occlusions.Retinal vascular occlusionsIRCT20130812014333N185Kermanshah University of Medical Sciences58
Completed
Not Applicable
The change of retinal sensitivity with intravitreal injection of aflibercept for wet type of age-related macular degeneration.wet type age-related macular degenerationJPRN-UMIN000015810Department of Ophthalmology and Visual Science Chiba University Graduate School of Medicine40